Copper Histidinate Treatment for Menkes Disease
NCT04074512
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Menkes Disease
Interventions
DRUG:
copper histidinate
Sponsor
Sentynl Therapeutics, Inc.